Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients-Reference-Cited by-同舟云学术

Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients

Published:2003-07-11 Issue:4 Volume:81 Page:349-354
ISSN:1395-3907
Container-title:Acta Ophthalmologica Scandinavica
language:en
Short-container-title:

Author:

Kałuz̊ny Jakub J.,Szaflik Jerzy,Czechowicz-Janicka Krystyna,Kałuz̊ny Józef,Orzalkiewicz Alicja,Zaleska Anna,Krajewska Malgorzata,Stewart Jeanette A.,Leech Jessica N.,Stewart William C.

Publisher

Wiley

Subject

Ophthalmology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1034/j.1600-0420.2003.00097.x/fullpdf

Reference35 articles.

1. The relationship between control of intraocular pressure and visual field deterioration;Advanced Glaucoma Intervention Study (AGIS;Am J Ophthalmol,2000

2. A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol or dorzolamide;Boyle;Ophthalmology,1999

3. A comparison of dorzolamide-timolol combination versus the concomitant drugs;Choudhri;Am J Ophthalmol,2000

4. A randomized trial comparing the dorzolamide/timolol combination to monotherapy with timolol or dorzolamide in patients inadequately controlled on timolol alone;Clineschmidt;Invest Ophthalmol Vis Sci,1998

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fixed-combination topical anti-hypertensive ophthalmic agents;Expert Opinion on Pharmacotherapy;2020-03-31

2. Parasympathomimetics;Glaucoma;2015

3. Melatonin and Its Analog 5-Methoxycarbonylamino-N-Acetyltryptamine Potentiate Adrenergic Receptor-Mediated Ocular Hypotensive Effects in Rabbits: Significance for Combination Therapy in Glaucoma;Journal of Pharmacology and Experimental Therapeutics;2013-04-16

4. GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin;Current Medical Research and Opinion;2010-03-15

5. Ophthalmologist Attitudes regarding Fixed Combination Treatment for Glaucoma in the European Union;European Journal of Ophthalmology;2009-07